↓ Skip to main content

Dove Medical Press

The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
5 X users
reddit
1 Redditor

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
17 Mendeley
Title
The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2024
DOI 10.2147/dmso.s447582
Pubmed ID
Authors

Riccardo Dalle Grave

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 12%
Lecturer 1 6%
Lecturer > Senior Lecturer 1 6%
Researcher 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 11 65%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Agricultural and Biological Sciences 1 6%
Social Sciences 1 6%
Medicine and Dentistry 1 6%
Other 0 0%
Unknown 12 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2024.
All research outputs
#15,670,529
of 26,510,312 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#455
of 1,220 outputs
Outputs of similar age
#155,349
of 385,883 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#6
of 31 outputs
Altmetric has tracked 26,510,312 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,220 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 385,883 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.